Sam Chun Dang Pharm. Co., Ltd

KOSDAQ:A000250 Voorraadrapport

Marktkapitalisatie: ₩3.2t

Sam Chun Dang Pharm Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Dae-In Yoon

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO7.0%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Investors Are Less Pessimistic Than Expected

Oct 05
Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Investors Are Less Pessimistic Than Expected

Sam Chun Dang Pharm (KOSDAQ:000250) Takes On Some Risk With Its Use Of Debt

Sep 08
Sam Chun Dang Pharm (KOSDAQ:000250) Takes On Some Risk With Its Use Of Debt

Subdued Growth No Barrier To Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) With Shares Advancing 44%

Jun 19
Subdued Growth No Barrier To Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) With Shares Advancing 44%

Is Sam Chun Dang Pharm (KOSDAQ:000250) A Risky Investment?

Jun 09
Is Sam Chun Dang Pharm (KOSDAQ:000250) A Risky Investment?

Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking

Mar 21
Optimistic Investors Push Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Shares Up 28% But Growth Is Lacking

Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly

Feb 26
Sam Chun Dang Pharm (KOSDAQ:000250) Seems To Use Debt Quite Sensibly

Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%

Feb 09
Investors Who Bought Sam Chun Dang Pharm (KOSDAQ:000250) Shares Five Years Ago Are Now Up 644%

Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?

Jan 05
Could The Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250) Ownership Structure Tell Us Something Useful?

Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly

Dec 01
Here's Why Sam Chun Dang Pharm (KOSDAQ:000250) Can Manage Its Debt Responsibly

CEO

Dae-In Yoon (74 yo)

no data

Tenure

Dae-In Yoon serves as the Chief Executive Officer and Chairman of Sam Chun Dang Pharmacy. Dae-In Yoon serves as Chief Executive Officer and Chairperson of Sam Chun Dang Pharm Co. Ltd. Dae-In Yoon serves as...